Effects of prebiotics on postprandial GLP-1, GLP-2 and glucose regulation in patients with type 2 diabetes: A randomised, double-blind, placebo-controlled crossover trial
dc.contributor.author | Birkeland, Eline | |
dc.contributor.author | Gharagozlian, Sedegheh | |
dc.contributor.author | Gulseth, Hanne L. | |
dc.contributor.author | Birkeland, Kåre I. | |
dc.contributor.author | Hartmann, Bolette | |
dc.contributor.author | Holst, Jens J. | |
dc.contributor.author | Holst, René | |
dc.contributor.author | Aas, Anne-Marie | |
dc.date.accessioned | 2022-08-01T08:29:55Z | |
dc.date.available | 2022-08-01T08:29:55Z | |
dc.date.created | 2021-09-02T10:25:47Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Diabetic Medicine. 2021, 1-10. | |
dc.identifier.issn | 0742-3071 | |
dc.identifier.uri | https://hdl.handle.net/11250/3009493 | |
dc.language.iso | eng | |
dc.title | Effects of prebiotics on postprandial GLP-1, GLP-2 and glucose regulation in patients with type 2 diabetes: A randomised, double-blind, placebo-controlled crossover trial | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 1-10 | |
dc.source.journal | Diabetic Medicine | |
dc.identifier.doi | 10.1111/dme.14657 | |
dc.identifier.cristin | 1930700 | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 |
Files in this item
This item appears in the following Collection(s)
-
Artikler [5068]
-
Publikasjoner fra CRIStin FHI [7544]